Castillo, L., Young, A. I. J., Mawson, A., Schafranek, P., Steinmann, A. M., Nessem, D., . . . Oakes, S. R. (2020). MCL-1 antagonism enhances the anti-invasive effects of dasatinib in pancreatic adenocarcinoma. Oncogene, 39(8), 1821-1829. https://doi.org/10.1038/s41388-019-1091-0
Citace podle Chicago (17th ed.)Castillo, Lesley, et al. "MCL-1 Antagonism Enhances the Anti-invasive Effects of Dasatinib in Pancreatic Adenocarcinoma." Oncogene 39, no. 8 (2020): 1821-1829. https://doi.org/10.1038/s41388-019-1091-0.
Citace podle MLA (9th ed.)Castillo, Lesley, et al. "MCL-1 Antagonism Enhances the Anti-invasive Effects of Dasatinib in Pancreatic Adenocarcinoma." Oncogene, vol. 39, no. 8, 2020, pp. 1821-1829, https://doi.org/10.1038/s41388-019-1091-0.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..